Breast cancer is the second most common cancer in women and metastasis is the leading cause of breast cancer-related mortality. While the factors leading to metastasis remain poorly understood, epigenetic changes in the cancer cell are likely strongly associated with the shift from primary tumor to metastasis. There are several breast cancer subtypes, the most aggressive of which is triple-negative breast cancer which is difficult to treat in part because it is prone to metastasis. In the early stages of metastasis, cells from the primary tumor invade the surrounding tissue before breaking away and seeding metastases. In some cases, tumor cells invade as clusters of cells that migrate as a group and maintain their cell-cell contacts through a process known as collective invasion. These clusters of collectively invading cells have been shown to seed circulating tumor cell clusters that are more efficient at forming metastases than single tumor cells. SUV420H2 is a histone methyltransferase that trimethylates histone H4 lysine 20 (H4K20me3), an epigenetic mark associated with transcriptional repression. Triple-negative breast cancer has lower levels of SUV420H2 and H4K20me3 levels than more luminal subtypes. Our lab and others have found that downregulation or inhibition of SUV420H2 promotes increased plasticity in the epithelial-to-mesenchymal transition, a transcriptional program associated with cancer metastasis. Our objective was to use a three-dimensional tumor spheroid system to determine the role of SUV420H2 and H4K20me3 on breast cancer invasion. We found that in immortalized non-tumorigenic breast cells grown as spheroids in an extracellular matrix, knockdown of SUV420H2 promotes invasion. Treatment of triple-negative breast cancer spheroids with an inhibitor of SUV420H2 (A196) also leads to an increase in invasion, as well as a shift in invasive phenotype from one where cells invade as single cells to a one where cells invade as collective chains emanating from the central spheroid. This suggests that reduced levels of SUV420H2 and the associated changes in histone marks and transcriptional programming in triple-negative breast cancer promote a phenotypic shift from single cell to collective invasion and may be one factor contributing to the increased metastatic potential of this subtype. Future studies will focus on characterizing the effects of SUV420H2 loss on gene and protein expression as well as chromatin in invading cells in tumor spheroids. Citation Format: Emily Campbell Whitt, Laura M. McLane, Paula M. Vertino. SUV420H2-mediated regulation of collective invasion in triple-negative breast cancer. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3597.
same cell. While the full scope of causes for this diversity is unknown, tension on the plasma membrane is a likely contributor, as each endocytosis event necessitates induced membrane curvature. Our results demonstrate that increased membrane tension impedes clathrin-mediated endocytosis (CME) through inhibition of initiation, formation and dissolution of clathrin-coated structures, and endocytic dynamics rapidly and locally reflect changes in membrane tension due to pharmacological and mechanical stimuli. We found that spatial and temporal heterogeneities in clathrin coat dynamics mark the tension gradients arising during cell spreading and migration. Spatiotemporal variations in CME are also observed during morphological changes shaping development of multicellular organisms. Collectively, our findings suggest that tension gradients in tissues can lead to patterning and differentiation through mechanoregulation of CME.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.